Submissions from 2019

Urine cell flow cytometry analysis of PD-L1 expression and DNA content for bladder cancer, P I. Chen, A Wang, Mustafa Deebajah, Shaheen Alanee, and B K. Patterson

Keynote-676: Phase 3 study of bacillus calmette-guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction, A M. Kamat, N D. Shore, N M. Hahn, Shaheen Alanee, H Nishiyama, S Shariat, K Nam, E Kapadia, T L. Frenkl, and G D. Steinberg

New persistent opioid use after ureteroscopy for stone treatment, C Tam, P Yan, J Raisky, V Gunaseelan, T Kim, David Leavitt, C Dauw, and J M. Hollingsworth